TG Therapeutics | Koszty Operacyjne



Operating Expenses Zmiana Data
AbbVie USD 9.61B 6.98B 2025-03
Alaunos Therapeutics USD 759K 391K 2024-12
Amgen USD 6.78B 401M 2024-12
Ardelyx USD 108M 12M 2024-12
Arrowhead Research USD 163.91M 1.71M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Biogen USD 2.01B 13.3M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Dynavax Technologies USD 73.66M 3.12M 2024-12
Gilead Sciences USD 4.43B 687M 2025-03
J&J USD 8.26B 10.37B 2025-03
Novartis USD 11.28B 1.73B 2024-12
PTC Therapeutics USD 275.66M 24.36M 2024-12
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
TG Therapeutics USD 78.24M 6.79M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



TG Therapeutics Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.